Leslie Salas Estrada of Filizola Laboratory thinks that the creation of drugs that block the kappa-opioid receptor may help to minimise opioid addiction. The problem is that screening billions of chemical molecules can take months, making it expensive and time-consuming to find drugs that can block the activity of a protein, such as the kappa-opioid receptor.
A class of drugs known as opioids is used to treat moderate to severe pain. It can be made synthetically or naturally from the opium poppy plant. They block the transmission of pain signals by binding to opioid receptors on nerve cells in the brain, spinal cord, gastrointestinal system, and other body organs.
Salas Estrada is employing artificial intelligence to streamline the process (AI). She is using computational methods that might improve its efficacy.
Similar trials are being carried out in Alberta by Canadian researchers. Researchers are trying artificial intelligence to estimate the risks linked with prescription opioids in light of the nation’s escalating drug overdose crisis.
Dr. Dean Eurich of the University of Alberta claims that machine learning might be better at identifying those who are most vulnerable. Thanks to the AI-assisted system, physicians may feel more at ease knowing there are other tools they can use to guarantee the patient is receiving the right drug at the right time.
Opioid use disorder affects about 30 lakh Americans. 80,000 Americans lose their lives to overdoses each year. Oxycodone, morphine, fentanyl, and heroin are all opioid medications that bind to opioid receptors.
Mu-opioid receptor activation results in euphoria and pain alleviation, as well as physical dependence and reduced breathing, both of which can cause drug overdose fatality. Preclinical research suggests that pharmacologically inhibiting kappa-opioid receptors may be a useful strategy for treating opioid dependence.
According to Salas Estrada, withdrawal symptoms can be very difficult to overcome and will eventually occur in people who are trying to stop using. If patients are exposed to opioids regularly, their brains are rewired to require more medication. According to her, it has been shown in animal models that inhibiting the kappa opioid receptor’s activity reduces the need for drug use throughout the withdrawal phase.
Salas Estrada argues that one advantage of artificial intelligence is its capacity to recognise patterns in enormous amounts of data. Machine learning can help in utilising the knowledge that can be learned from huge chemical databases in order to build novel drugs from scratch. She continued that by doing this, it might be able to reduce the amount of time and money needed for drug discovery.
According to Dr. Fizza Gliani of the College of Physicians and Surgeons of Alberta, machine learning could be a helpful tool for reducing hospital stays and morbidity for patients once it is integrated into the healthcare system. According to Gliani, when current methods are unable to pinpoint the origins of danger, there may be more complex medical solutions available than merely reducing a patient’s opioid intake.
